Elegen develops cell-free gene synthesis platforms using microfluidics, AI, and robotics to produce high-quality synthetic DNA.[2]
Get notified the moment Elegen files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.